Options Traders Coming After Calls in UTHR

Shares of United Therapeutics Corp. UTHR are higher on the session by 4.43%, currently trading at $54.04. The stock has been moving largely higher over the past few weeks. Options traders were coming after the calls right at the opening bell today. Though action ahs been primarily in small lots, call volume is now running at over 6x the daily average, all of which ahs been purchases on the offer. Traders are buying the $55.00 and $60.00 strikes in October, 345 times and 455 times, respectively; volume exceeded open interest on both strikes. United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of products to address the medical needs of patients with chronic diseases. The company's principal therapeutic platforms include Prostacyclin Analogs, Phosphodiesterase Type 5 inhibitors, Monoclonal Antibodies and Glycobiology Antiviral Agents. Prostacyclin Analogues are stable synthetic forms of prostacyclin. Learn how to find the best stocks to trade each day in our 70 page E-Book and 90 minute online video for free.